News Focus
News Focus
Followers 4
Posts 332
Boards Moderated 0
Alias Born 12/22/2014

Re: None

Thursday, 01/24/2019 6:10:24 PM

Thursday, January 24, 2019 6:10:24 PM

Post# of 48316
Does anyone have a somewhat closer contact to the company?

I was wondering, I sent a mail at the beginning of the week (Monday early, early morning) about two items:

a) The SSL certificate for the pisces micro website expired (it's the top most link with yellow background from the main Oncosec.com website and directs to https://www.piscesclinicaltrial.com/). It's still not repaired and patients that might want to inform themselves about the trial will see a big red warning in their browser.

b) I asked if the statistical assumptions behind the changed trial design has been made public anywhere. One should note that you cannot simply use the standard formulas* because we have done an "unblinded sample size re-estimation", i.e. peeked at the results.

I did not receive a reply yet and the https://www.piscesclinicaltrial.com/ website still has an invalid certificate. So I wonder, has anyone spoken with the company recently? How fast does their investor relations react?

Thx

dM





* You need to do some correction as Koyama & Chen 2007 (https://onlinelibrary.wiley.com/doi/abs/10.1002/sim.3123). If you're not competent enough and "forget" that, this might complicate approval, see e.g. the pages in https://www.ema.europa.eu/documents/variation-report/opdivo-h-c-3985-ii-0030-epar-assessment-report-variation_en.pdf where Koyama/Chen is mentioned (and yes, it's quite astonishing that a company as large as BMS forgot that!).

[edit: make it three items - I also inquired about a presentation that I could not find on the website, the one here https://ir.oncosec.com/press-releases/detail/1959/oncosec-chief-scientific-officer-to-present-at-advances-in]
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y